logo
15:47 Feb 25

Bal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
75.62
-0.41 (-0.54%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bal Pharma Ltd. Financials

Bal Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
75.62
-0.41 (-0.54%)
15:47 Feb 25
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

59/100
Affordable Valuation

Technical

50/100
Technically Neutral

Strength

10

Weakness

2

Opportunity

0

Threats

0

9.32 %

ROE %

2.14 %

ROA %

5.10

EPS

48.62

BVPS

2.38 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
250.53 281.21 304.22 339.22 303.08
Operating Expenses +
226.07 257.73 279.09 307.69 273.53
Raw Material
145.9 172.42 190.64 192.82 164.95
Increase Decrease in Cost
5.05 -4.89 -17.87 -1.06 -7.05
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
41.88 47.25 55.3 60.38 62.4
Miscellaneous Expenses
54.1 59.81 73.92 78.03 83.35
Operating Profit
24.46 23.48 25.13 31.53 29.55
Other Income
1.14 5.15 0.94 2.85 2.2
Depreciation
9.52 9.04 9.13 10.07 9.77
Interest
11.97 10.41 12.19 15.26 16.85
Profit before tax and exceptio..
4.1 9.18 4.75 9.05 5.14
Exceptional Items
0 0 0 0 0
PBT
4.1 9.18 4.75 9.05 5.14
Provision for Taxation
-0.61 3.48 2.13 1.6 -2.1
Net Profit
4.71 5.7 2.62 7.45 7.24
NET Profit after MI
4.74 5.61 2.57 7.39 7.22
EPS
3.34 3.79 1.67 4.94 4.54
Operating Profit Margin (%)
9.76 8.35 8.26 9.29 9.75
Net Profit Margin (%)
1.89 2 0.84 2.18 2.38

Bal Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 50.90 50.90 50.90 50.90 50.90 50.90
FII 0.10 0.20 0.20 0.10 0.10 0.10
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 49.00 48.90 48.90 49.00 49.00 49.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: